These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22292739)

  • 41. Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist.
    Shibata A; Uga K; Sato T; Sagara M; Igaki K; Nakamura Y; Ochida A; Kono M; Shirai J; Yamamoto S; Yamasaki M; Tsuchimori N
    Biochem Pharmacol; 2018 Apr; 150():35-45. PubMed ID: 29369782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.
    Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM
    Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
    Park TY; Park SD; Cho JY; Moon JS; Kim NY; Park K; Seong RH; Lee SW; Morio T; Bothwell AL; Lee SK
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18673-8. PubMed ID: 25527718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune disease.
    Chang C; Loo CS; Zhao X; Solt LA; Liang Y; Bapat SP; Cho H; Kamenecka TM; Leblanc M; Atkins AR; Yu RT; Downes M; Burris TP; Evans RM; Zheng Y
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18528-18536. PubMed ID: 31455731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bob1 enhances RORγt-mediated IL-17A expression in Th17 cells through interaction with RORγt.
    Ikegami I; Takaki H; Kamiya S; Kamekura R; Ichimiya S
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1167-1171. PubMed ID: 31103264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein.
    Xu T; Wang X; Zhong B; Nurieva RI; Ding S; Dong C
    J Biol Chem; 2011 Jul; 286(26):22707-10. PubMed ID: 21566134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eriodictyol suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis.
    Yang T; Li X; Yu J; Deng X; Shen PX; Jiang YB; Zhu L; Wang ZZ; Zhang Y
    Food Funct; 2020 Aug; 11(8):6875-6888. PubMed ID: 32686813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Th17 Cells and autoimmune encephalomyelitis (EAE/MS).
    Aranami T; Yamamura T
    Allergol Int; 2008 Jun; 57(2):115-20. PubMed ID: 18427164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis.
    Yamashita T; Iwakura T; Matsui K; Kawaguchi H; Obana M; Hayama A; Maeda M; Izumi Y; Komuro I; Ohsugi Y; Fujimoto M; Naka T; Kishimoto T; Nakayama H; Fujio Y
    Cardiovasc Res; 2011 Sep; 91(4):640-8. PubMed ID: 21622681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of retinoic acid-related orphan receptor γ(t) by parabens and benzophenone UV-filters.
    Inderbinen SG; Kley M; Zogg M; Sellner M; Fischer A; Kędzierski J; Boudon S; Jetten AM; Smieško M; Odermatt A
    Toxicology; 2022 Apr; 471():153159. PubMed ID: 35337918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retinoid-related orphan receptor gamma regulates several genes that control metabolism in skeletal muscle cells: links to modulation of reactive oxygen species production.
    Raichur S; Lau P; Staels B; Muscat GE
    J Mol Endocrinol; 2007 Jul; 39(1):29-44. PubMed ID: 17601883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinoid X receptor agonists modulate Foxp3⁺ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation.
    Takeuchi H; Yokota-Nakatsuma A; Ohoka Y; Kagechika H; Kato C; Song SY; Iwata M
    J Immunol; 2013 Oct; 191(7):3725-33. PubMed ID: 23980207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Critical Role of P2Y
    Qin C; Zhou J; Gao Y; Lai W; Yang C; Cai Y; Chen S; Du C
    J Immunol; 2017 Jul; 199(1):72-81. PubMed ID: 28515278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells.
    Lochner M; Peduto L; Cherrier M; Sawa S; Langa F; Varona R; Riethmacher D; Si-Tahar M; Di Santo JP; Eberl G
    J Exp Med; 2008 Jun; 205(6):1381-93. PubMed ID: 18504307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
    Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
    J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt.
    Jiang X; Dulubova I; Reisman SA; Hotema M; Lee CI; Liu L; McCauley L; Trevino I; Ferguson DA; Eken Y; Wilson AK; Wigley WC; Visnick M
    Bioorg Med Chem Lett; 2020 Mar; 30(6):126967. PubMed ID: 32005415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis.
    Klemann C; Raveney BJ; Klemann AK; Ozawa T; von Hörsten S; Shudo K; Oki S; Yamamura T
    Am J Pathol; 2009 Jun; 174(6):2234-45. PubMed ID: 19389933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.
    Xue X; Soroosh P; De Leon-Tabaldo A; Luna-Roman R; Sablad M; Rozenkrants N; Yu J; Castro G; Banie H; Fung-Leung WP; Santamaria-Babi L; Schlueter T; Albers M; Leonard K; Budelsky AL; Fourie AM
    Sci Rep; 2016 Dec; 6():37977. PubMed ID: 27905482
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.